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ABBREVIATIONS 
ACS  - Acute coronary syndrome 
A   - Late diastyolic velocity 
A’   -  Late diastolic tissue velocity 
AMI   -  Acute Myocardial Infarction 
AWMI  -  Anterior Wall Myocardial Infarction 
AV  - Atrioventricular  
BMI   -  Body Mass Index 
BSA   -  Body Surface Area 
CABG  -  Coronary Artery By-Pass Graft 
CAD   -  Coronary Artery Disease 
CAG   -  Coronary Angiogram 
CHF   -  Congestive Heart Failure 
CHB   -  complete heart block 
CSA   -  chronic stable angina 
DVD   -  Double Vessel Disease 
EA   -  Effort angina 
E  -  Early diastolic velocity 
E’   -  Early diastolic tissue velocity 
E/E’- Ratio of early diastolic velocity and early diastolic tissue velocity 
E’/A’ – Ratio of early diastolic tissue velocity and late diastolic tissue 
velocity 
IR                 -        Isovolumic relaxation phase 
IWMI  - Inferior Wall Myocardial Infarction 
LAD   - Left anterior descending artery 
LCA   -  Left circumflex artery 
LV   -  left ventricle  
LVEF  -  Left Ventricular Ejection Fraction 
MI                 -          Myocardial  Infarction 
MR   -  Mitral Regurgitation 
RCA              -          Right Coronary Artery 
SD                 -          Standard Deviation 
SVD   -  Single Vessel Disease 
TDI   -  Tissue Doppler echocardiography 
TVD   -  Triple Vessel Disease 
WMA  -  wall motion abnormality 
 
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INTRODUCTION 
 
    INTRODUCTION 
  Coronary artery disease (CAD) is one of the leading cause of 
morbidity and mortality in the world and has nearing its epidemic 
proportions. Coronary artery disease causes 9.4 percent of total deaths (25 
lakhs) in under developed countries and 16.3 percent (13 lakhs) of all 
deaths in developed countries1. The world health organisation (WHO) has 
calculated the year of 2002 alone, 12.6 percent of deaths in the world were 
because of CAD2.  The proportion of CAD is expected to increase as it is 
disease of aging and the world population getting older. 
  The India has similar scenario, Indian studies has revealed  
that cardiovascular diseases (CVD) cause about 40% of deaths in the urban 
areas and 30% of deaths in rural areas in india3. Prevalence of  cardio 
vascular disease  in the adult population has multiplied in urban areas from 
around 2% in early 1960’s to 6.5% in late 1970’s, 7% during  the year 
1980, to close  10 % in 1990 and to a critical 10.5% in the year 2000, the 
same time  in rural areas, it is  increased to a smaller  extent from about 2% 
during  1970, to 2.5% in late 1980’s ,  and to calculated 4% in the 1990, at 
last the prevalence has reached  4.5% in 2000. 
  So prevention of cardiovascular diseases among people is 
more important, if cardiovascular disease occurs the earlier detection and 
treatment for the prevention of complication and death. Moreover 
identification of risk factors and prevention of CAD is more important than 
treatment itself. Early detection of CAD among people with or without 
symptoms is main task to reduce morbidity and mortality. There are 
various invasive and non invasive methods to detect CAD among people 
with symptoms. Always invasive methods have it own advantage and 
disadvantages, so non invasive tests are low cost modalities of CAD 
detection, and are need of the hour. Of these non invasive modalities 
various methods used like ECG, ECHO, CT, MRI and nuclear imaging. 
Many non invasive methods are used for detection of CAD. Exercise  stress  
testing like treadmill test, stress echocardiography  and stress SPECT  is  
routinely  used  for  the  non invasive  assessment  of  coronary  artery  
disease  and  is  considered  a safe procedure.  
  Diastolic stress test mainly used to diagnose elevated filling 
pressure in patients with exertional dyspnoea associated with normal filling 
pressure at rest. The elevated filling pressure during exercise reflects 
cardiac cause of dyspnoea, this can be measured by early mitral velocity 
(E) and early mitral tissue velocity (E’). This idea extrapolated in patients 
with chest pain with normal LV function to identify myocardial ischemia 
which increases LV filling pressure. 
  Based on the concept diastolic abnormalities occur earlier than 
symptoms, electrocardiographic changes and systolic dysfunction during 
myocardial ischemia. Diastolic stress test should identify ischemia earlier 
than other type of stress test methods4.  My study is looking into these 
questions and answers. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AIM OF THE STUDY 
 
     AIM OF STUDY 
1. To calculate tissue Doppler velocity parameter  in normal and 
coronary artery disease patients 
2. To measure changes in TDI parameters immediately after stress 
3. To identify changes in E/E’ during normal and after stress 
4.  Changes in E/E’ can detect coronary artery disease and its severity 
 
 
 
 
 
 
 
 
 
 
     
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
REVIEW OF LITERATURE 
 
    REVIEW OF LITERATURE 
   Since introduction of exercise echocardiography more 
than thirty years ago5, a significant progress has been made to use it to 
detect coronary artery disease. Stress echocardiography commonly used to 
detect myocardial ischemia by identification of wall motion abnormalities 
during stress. However stress echocardiography is done by using various 
methods like pharmacological agents and exercise which detects wall 
motion abnormalities chiefly systolic changes. So detection of diastolic 
changes during stress was not possible initial days of echocardiography. 
Detection of diastolic changes during stress possible and pressure changes 
estimated invasively. These diastolic changes can be measured non 
invasively by Doppler echocardiography mainly tissue Doppler 
echocardiography. The non invasive measurement of exercise induced 
diastolic changes demonstrated by Ha et al6 in 2005. They designed 
echocardiographic stress test to detect diastolic changes, which was named 
“DIASTOLIC STRESS TEST”.  
   The diastolic stress test using echocardiogram was 
demonstrated to detect changes in LV filling and LV diastolic pressure 
during stress non invasively7. They combined supine bicycle exercise and 
tissue Doppler echocardiography to do diastolic stress test.  
    Diastolic stress echocardiography performed by 
measuring diastolic myocardial tissue velocity at rest followed by during 
exercise, which detected changes in diastolic parameters. During diastolic 
stress test traditional transmitral Doppler and tissue Doppler parameters 
like E, A, DT, E/A, S’, E’ and A’ were measured. LV filling pressure 
reliably estimated using mitral inflow early diastolic velocity (E) and early 
diastolic tissue velocity (E’). Increase in left ventricular filling pressure 
occurs in patients with diastolic dysfunction which can be estimated by 
ratio of early mitral diastolic velocity and early mitral tissue Doppler 
velocity (E/E’).   
   The exercise induced diastolic dysfunction causes 
increase in LV filling pressure which can be measured by ratio of early 
mitral diastolic velocity (E) and early mitral tissue Doppler velocity (E’). 
The non invasive measurement of left ventricular filling pressure by E/E’ 
ratio is well correlated with invasive measurements by various authors and 
in various studies8. This ratio also used to identify subjects with elevated 
LVEDP during exercise and lower exercise capacity9. Initially the diastolic 
stress echocardiography was used to evaluate patients with exertion 
dyspnoea and dyspnoea of unknown origin. It also used to differentiate the 
cause of dyspnoea from cardiac or non cardiac origin. Ha et al applied this 
diastolic stress echocardiography to patients with exertion dyspnoea who 
had no evidence of increased left ventricular filling pressure at rest. Their 
study show  36% patients had increase in left ventricular filling pressure on 
the basis of E/E’ ratio during stress.  Diastolic stress test also differentiates 
patients with organic heart disease who have normal hemodynamic and 
asymptomatic during resting state and symptoms precipitated only during 
exertion. The patients with exertion dyspnoea which is not explained by 
normal cardiac performance at rest, but they can have change in LV 
diastolic parameters during exercise compared with those who don’t have 
symptom of exertion dyspnoea despite same LV systolic and diastolic 
function during rest.  
 Diastolic stress echocardiography: 
   Patients with diastolic dysfunction have abnormalities 
of relaxation that prevents augmentation of relaxation when heart rate 
increases with exercise, thereby increase LV filling pressure and LA 
pressure. This technique can be used to detect increase in left ventricular 
filling pressure during exercise in patients with exertion dyspnoea and 
normal resting LV systolic and diastolic function. Tissue Doppler imaging 
is one of the methods to evaluate diastolic function or myocardial 
relaxation by measuring mitral annular velocity in diastole.  
 
Diastolic functional reserve: 
   Diastolic functional reserve defined as capacity of the 
ventricle to augment or increase diastolic filling needed for increase in 
demand of cardiac output without increase in ventricular filling pressure.  
Uses of diastolic stress test: 
1. Differentiate and gives diagnostic finding that useful in management 
of  patients with dyspnoea of unknown aetiology  
2. To detect coronary artery disease 
3. To determine exercise capacity 
Mechanism of diastolic dysfunction during ischemia 
   Myocardial relaxation is an active process and energy 
demanding process therefore it vulnerable to ischemia10, 11. So it has been 
shown that recurrent myocardial ischemia can induce structural change of 
the myocardium which leads to impaired early diastolic motion12. These 
changes in diastolic wall motion can be detected by Tissue Doppler 
imaging (TDI) at rest in ischemic regions13. TDI can quantify regional 
myocardial function. In experimental studies showed myocardial velocity 
falls progressively 15 secs after onset of ischemia14. The measurement of 
myocardial velocity has been proposed an objective marker of myocardial 
function during stress. Regional stunning due to myocardial ischemia can 
be diagnosed by tissue Doppler measurements. The myocardial ischemia 
can also be detected by measurement of reduced transmyocardial velocity.   
These regional diastolic dysfunction can be detected and measured by TDI, 
so TDI parameters like systolic velocity (S’), early diastolic velocity (E’), 
and late diastolic velocity (A’) can reflect changes during ischemia. 
Changes documented during ischemia are reduced and delayed peak 
systolic and diastolic velocities, reduced myocardial velocity gradients and 
diastolic dysfunction, which demonstrated in various studies. In post 
treadmill exercise echocardiography also identifies diastolic dysfunction 
immediately after cessation of exercise, Because  diastolic  dysfunction  
may  persist after recovery  of  normal  systolic  function,  after  short time 
of  coronary occlusion by balloon during coronary angioplasty15. 
    LV walls like anterior, IVS, inferior, posterior and 
lateral are divided into basal, mid and apical segments.  These segments 
have individual velocities, which can vary segments to segment. Some 
studies measured basal and mid segments16 and some studies measured 
only basal segments 17. But during ischemia velocity and gradient from 
base to apex is altered or reduced. And LV apex relatively an immobile 
structure, so measurement of velocity in basal segments ideal to detect 
ischemia induced velocity changes.  
   In a study by Hoffman 17 et showed the global early 
diastolic tissue velocity E’ was reduced in one and two vessel disease and 
normal in three vessel disease. Global late diastolic tissue velocity A’ was 
increased in one vessel disease and not increased in two and three vessel 
disease. The E’/A’ reduced in one vessel disease. Regional systolic velocity 
S’ was lower in ischemic segments of the vessel supplied and S’ 
significantly lower in three vessel disease.   
The TDI parameters described by Hoffman et al given as follows  
TDI parameters NON- CAD CAD 
S’ 6.06+- 0.89 5.58+- 0.96 
E’ 6.78+- 1.46 6.31+-1.65 
A’ 7.16+-1.32 7.16+-1.53 
E/E’ 10.4+-2.66 11.6+-3.99 
 
   Garcia et al18showed regional myocardial ischemia 
causes reduction of early diastolic tissue E’ velocity in animal models, 
following this demonstrations pouleur et al19 showed E’ velocity reduced 
during myocardial ischemia in humans. The significant reduction of early 
diastolic velocity E’ in ischemic region demonstrated in patients with one 
vessel disease, two vessel disease and three vessel disease 18. The reduction 
in early diastolic velocity E’ might be caused by increased LV filling 
pressure as myocardial ischemia worsens. In patients with one vessel 
disease the early diastolic velocity E’ of the segment supplied by stenotic 
artery decrease and late diastolic velocity A’ increases resulting  in 
significant reduction of E’/A’. As severity of CAD increases and involving 
more than one vessel this late compensation was lost and decline in global 
diastolic and systolic function follows.  
   Important landmark MYDISE16 (myocardial Doppler in 
stress echocardiography) study done by using pharmacological agents 
(dobutamine) and it showed mean systolic velocity was less in women than 
men and inverse relation between age and systolic velocity at peak exercise 
or peak stress. Peak systolic velocity at peak stress correlated with height. 
Patients with CAD had lower peak systolic velocity than non CAD group.  
Peak systolic velocity increases > 100% in healthy volunteers than 50-70% 
in patients with CAD. MYDISE study demonstrated peak systolic velocity 
at peak stress was better discriminator of disease. The average peak systolic 
velocity in basal anterior segment, basal lateral and basal inferior segments 
are 10.3cm/sec, 10.8cm/sec and 12.8 cm/sec respectively. Above these 
following cut of systolic velocity(S’) in a myocardial segment clearly 
discriminates without coronary artery disease.  
 
The average peak cut off systolic velocity of myocardial segments with 
CAD in MYDISE study 
Myocardial segments Systolic velocity (S’) cm/sec (avg) 
Basal anterior 10.3 
Basal lateral 10.8 
Basal inferior 12.8 
 
The MYDISE study showed sensitivity and specificity of individual 
coronary artery stenosis by diastolic stress echocardiography with above 
cut of systolic velocity as follows 
ARTERY  SENSITIVITY SPECIFICITY 
LAD 80% 80% 
LCX 91% 80% 
RCA 93% 82% 
 
    A diastolic stress test study by tsougos et al20 
demonstrated positive treadmill exercise test was observed in 68% patient 
and wall motion abnormality observed in 76% of patients with CAD group. 
The E/E’ ratio is similar in septal and lateral wall in resting stage. This 
study showed CAD group had an increase of E/E’ average compared with 
the non-CAD group: 56 of 72 patients (78%) versus 10 of 42 patients 
(24%) (P <0.001). This study obstructive CAD group had increase of E/E’ 
average immediately after exercise, the sensitivity of the method is 77.8%, 
the specificity 76.2%, and the accuracy 77.2%. The patients with an 
exercise-induced increase of E/E’ average, 85% had CAD and 15% no 
CAD. But the patients with no exercise-induced increase of the ratio 33% 
had CAD, and 67% had no CAD. The treadmill test duration was 
6.9±2.1min in patients with exercise-induced increase of E/E’ average 
compared with 6.8±1.9min in patients without increase of the ratio. 
   Zagatina et al21 demonstrated application of TDI in 
exercise echocardiography to detect coronary artery disease, they 
concluded that TDI gives highly reproducibility and minimal variation in 
inter observer variability. They studied 123 patients with TDI of systolic 
and diastolic function during stress echocardiography.  Patients with 
negative treadmill test and normal coronaries compared to positive 
treadmill test and abnormal coronaries had higher exercise capacity, peak 
systolic BP and peak HR. In this study subjects without CAD had higher 
exercise capacity (127.9 W) compared to with CAD (93.9W). The peak HR 
and sysytolic BP during stress was higher in patients without CAD (131.7 
beats/min) (177.7 mmhg) than with CAD (114.9 beats/min) (162 mmhg). 
   Systolic tissue Doppler velocity is better predictor of 
CAD than diastolic tissue Doppler velocity after exercise. The mid septal 
wall maximum systolic velocity  post-stress (5.68 +1.62 cm/s) in CAD 
compared to non  CAD (8.02 + 1.72) and P value  <0.001. the basal 
anterior wall maximum systolic velocity  post-stress (6.42 + 2.26cm/s) in 
CAD  compared to non  CAD (11.8 + 3.58) and P value of < 0.005. The 
mid lateral wall mean systolic velocity post stress (3.01 + 1.25 cm/s) in 
CAD compared to non CAD (5.34 + 1.81) and P value of < 0.005. the early 
diastolic tissue velocity (E’) post-stress (10.9 + 2.92 cm/s) in CAD 
compared to non  CAD (14.0+5.10) and P value of <0.05. They showed 
CAD without LAD disease had reduced systolic and diastolic velocity 
compared to normal subjects; however involvement of LAD significantly 
reduced all above velocities.  Diastolic tissue Doppler velocity predicts 
CAD earlier than systolic tissue Doppler velocity. It showed sensitivity, 
specificity and accuracy to detection stenosis in LAD as 96.1%, 62.4% and 
86.2% respectively. The sensitivity, specificity and accuracy for the 
detection LCX disease was 87.7%, 66% and 78.3% respectively. However 
it doesn’t give any criteria to diagnose RCA stenosis. 
   Williams et al22 investigated 26 patients for systolic 
velocity, diastolic velocity, strain rate and strain in normal coronaries and 
CAD without infarction. They followed treadmill test followed by 
immediate echocardiography to measure tissue velocity. The measurements 
at rest and peak exercise and post TMT for one hour with intervals. Tissue 
velocity measurements were taken at basal segments. The mean exercise 
time was 20% lower in CAD group than non CAD group. 
   Peak systolic velocity increases by 30% in CAD group 
than 92% in non CAD group. The small increase in systolic velocity of 
ischemic myocardium is due to tethering effect of adjacent normal 
myocardium23. The diastolic velocity E’ and A’ doesn’t change in CAD 
group during peak stress but both were increased in non CAD group 24, 25. 
But diastolic strain rate decreases by 24% in early diastole and 28% during 
atrial contraction.  
   Bolognesi et al26 evaluated patients with CAD with 
normal EF for invasive hemodynamic measurements combined with tissue 
Doppler imaging, and found suction like effect during early diastolic filling 
significantly reduced in early stages of CAD. It showed peak E velocity 
(cm/s) without CAD  75.0 ± 13.2 compared to with CAD  55.2 ± 12 P 
value  <.01 significantly reduced in contrary to latest studies. The peak A 
velocity (cm/s) 59.0 ± 4.5; 58.15 ± 14.8) was same in patients with or 
without CAD. However the peak systolic tissue velocity (S’) and diastolic 
tissue velocity (E’, A’) were significantly reduced in patients with CAD 
than normal group. The E’ velocity was lower and E’ acceleration time 
longer than non CAD group which explained by weakness of elastic 
properties of LV and reduced early diastolic recoil of LV due to myocardial 
ischemia.  
   Dounis et al27 studied type 2 DM and diabetic CAD 
patients with normal EF by tissue Doppler imaging for systolic and 
diastolic myocardial velocity. They showed decreased early diastolic tissue 
velocity in diabetics than control subjects (8.8±1.8 vs 10.1±1.7 cm/s; 
p=0.02). E’ was inversely correlated with age, HbA1c and pulse pressure. 
Moreover the reduction of early diastolic tissue velocity in diabetics was 
similarly to diabetic CAD. They concluded that impaired diastolic function 
in diabetics similar to diabetic CAD.  Bruch C et al 28 concluded that TDI 
useful to detect CAD using diastolic parameters in patients with normal 
systolic function. 
Diastole physiology: 
   The cardiac cycle has systolic ejection period and 
diastolic ﬁlling period. The systolic and diastolic function must increase 
with increase in demand such as exercise and others. The ventricle diastolic 
function has to increase with demand without increase in LA pressure.  Left 
ventricular diastole starts with aortic valve closure and it includes 
following phases of diastole 
1. Isovolumic relaxationIR) 
2. Rapid filling 
3. Slow filling 
4. Atrial contraction(AC) 
 
 The above diagram shows LV diastole during normal filling pressure 
and elevated filling pressure (high EDP) 
   Both ventricles are initially filled by the pressure 
gradient and finally by the respective atrial contraction. Isovolumetric 
relaxation phase starts with aortic valve closure until mitral valve opening 
during which ventricular pressure reduces to lower levels without 
significant changes of both ventricular volumes. During isovolumic 
relaxation phase ventricular pressure falls from peak that attained at the end 
of cardiac systole. This IR phase is energy dependent and may be more 
vulnerable to myocardial ischemia. During rapid filling phase majority of 
the ventricular filling occurs which is also energy dependent but partially. 
When both ventricular pressures drops lower than atrial pressure, AV 
valves opens and the blood flows from atrium to the ventricles. As rapid 
filling wave progresses increase in ventricular volume is affected by LV 
myocardial characteristics especially stiffness.  
    In slow filling phase as both ventricles go on to 
fill with blood, the intraventricular pressure starts going up as the ventricles 
became less compliant. So the decrease in pressure gradient across the 
atrioventricular valve causes decrease in ventricular filling. The slow filling 
phase is also affected by the above myocardial characteristics especially 
stiffness. Myocardial passive stiffness can be increased by fibrosis resulting 
from many factors such as myocardial ischemia, myocardial infarction, 
infiltrating process like amyloidosis, myocyte hypertrophy and valvular 
heart disease. About 85-90% of the both ventricular filling takes place at 
the end of the phase. The atrial contraction phase contributes to about 10-
15% of ventricular filling however in certain diseased states and older age 
it  may even contributes to about 30-40% (due to diminished early 
relaxation).     
Normal diastolic filling pattern:  
 In normal young adults, LV relaxation is an 
active process and maximum LV filling occurs during early diastole. Thus 
echocardiography characteristics as follows 
1. E/A ratio > 1.5 
2. Decceleration time (DT)- 160-240 ms 
3. Septal E’ > 10cm/sec 
4. Lateral E’ >15cm/sec 
5. E/E’ < 8 
6. Vp > 50 cm/sec 
 In normal myocardial relaxation, mitral 
inflow early diastolic velocity E is greater than late diastolic velocity A, so 
E/A usually more than 1.5. which reflects in mitral annular longitudinal 
velocity pattern E’ is always greater than A’. The lateral annulus velocity 
(normal E’>15cm/sec) is usually higher than septal annular velocity 
(normal E’ > 10cm/sec).so early mitral annulus velocity E′ always 
increases with exercise in normal young adults.  So the E/E′ is same at rest 
and during exercise (usually <8).  In older age there is gradual decline in 
rate of myocardial relaxation. So there is slowing of LV pressure decline 
and slow myocardial relaxation mimics grade 1 diastolic dysfunction. So at 
the age of 65 E velocity equals A velocity, and in age greater than 70 years 
the E/A ratio reverses that is < 1.0. In older age group the reversal of E′/A′ 
occur 10 to 15 years earlier than E/A. 
Normal diastolic function and aging: 
 Normal aging was shown to affect diastolic 
ventricular relaxation and diastolic filling in healthy adults. Factors that 
slow LV relaxation in most normal individuals are increase in systolic 
blood pressure and LV mass, which leads to changes in LV diastolic 
parameters. Most of elderly subjects will have equal reversal of peak E and 
peak A velocity at the age of 70. In individuals without elevation of blood 
pressure and LV mass still can have normal E and A pattern of diastolic 
function.  TDI velocity also age dependent, there was no difference in 
systolic velocity but early diastolic tissue velocity E’ and late diastolic 
tissue velocity A’ reduced in elderly subjects 29, 30. 
Factors affecting LV diastolic function: 
External factors: 
Pericardial factors like retriction and constriction 
Ventricular factors 
Extrinsic factors like fluid, mass and others 
 
Internal factors: 
LV characteristics like compliance and stiffness 
LV wall thickness due to muscle, fibrosis, amyloid and others 
Diastolic rigor, tone, contracture 
LV recoil like suction effect 
Viscoelastic properties of LV like creep 
Assessment of diastolic function: 
   Echocardiography evaluation of diastolic function is an 
integral part of cardiac assessment. There are various technique and 
parameters recommended to evaluate diastolic function and validation of 
these parameters done with invasive measurements. The TDI assessment of 
diastolic function is less load dependent than by Doppler transmitral 
velocity which is preload dependent. The methods for evaluation of 
diastolic function are 2D echo, Doppler echo, TDI, colour M mode, mitral 
and pulmonary artery flow velocity.  
Doppler echocardiography: 
    Doppler echocardiography is used to measure 
blood velocity using RBC’s as targets. Doppler echocardiography measures 
low amplitude, high velocity (10-150cm/sec) signals.   
Mitral flow velocity: 
    The mitral flow velocities were recorded with 
pulsed wave Doppler with the sample volume placed at the tip of the mitral 
valve from the apical four-chamber view. From the mitral valve inflow 
velocity curve the following measurements were made: peak E-wave 
velocity and its DT, peak A-wave velocity, and the isovolumic relaxation 
time were measured from aortic valve closure to the mitral valve opening. 
    The transmitral velocities (E and A wave) are 
directly related to left atrial pressure (preload) and independently and 
inversely related to ventricular relaxation. So mitral inflow patterns are 
highly sensitive to preload and its changes. This can change dramatically as 
diastolic dysfunction progresses, the use of mitral valve inflow patterns to 
assess diastolic function remains limited. 
 
 
 
 
 
 
 
 
Normal mitral inflow parameters as follows, 
Mitralinflow  
parameters 
Age group 
45-49 
 
50-54 
 
55-59 
 
60-64 
 
65-69 
 
Ewave  
m/sec 
0.7  
0.5-0.9 
0.6  
0.5-0.9 
0.7  
0.5-0.9 
0.7  
0.5-0.9 
0.6  
0.4-0.8 
0.6  
0.4-1.0 
Awave m/sec 
0.5  
0.3-0.7 
0.5  
0.4-0.8 
0.6  
0.4-0.9 
0.6  
0.4-0.9 
0.7  
0.4-1.0 
0.8  
0.5-1.1 
E/A ratio 
1.3  
1.0-2.0 
1.2  
0.8-2.0 
1.2  
0.7-1.8 
1.0  
0.7-1.6 
1.00 
0.6-1.50 
0.8  
0.6-1.3 
DT  msec 
208  
180-258 
217  
178-266 
210  
183-187 
222  
180-282 
227 
188-298 
242 
188-320 
 
Tissue Doppler imaging: 
    Tissue Doppler imaging is an ultrasonographic 
method to image and measure velocity of myocardial tissue with modified 
pulse wave Doppler echocardiography.  Myocardial velocity is much lower 
than blood (1-2cm/sec) but higher amplitude. So the Doppler principle 
modified to quantify higher amplitude, lower velocity signal of myocardial 
tissue motion. The sample volume was placed at the junction of the LV 
wall with the mitral annulus of the septal and lateral myocardial segments 
from the four-chamber view and inferior and anterior myocardial segments 
>70 
from the two-chamber view. It can also be measured in mid segments of 
LV wall. Peak velocities during systole (S’), early diastole (E’), and late 
diastole (A’) were measured. 
   Because the apex remains relatively stationary 
throughout the cardiac cycle, mitral annular motion is a good surrogate 
measure of overall longitudinal left ventricular (LV) contraction and 
relaxation.31  
 
Limitation of TDI: 
The important limitations to Tissue Doppler imaging modality is, it 
measures only the vector of motion that is parallel to the direction of the 
ultrasound beam. In addition, TDI measures absolute tissue velocity and is 
unable to discriminate passive motion (related to translation or tethering) 
from active motion (fiber shortening or lengthening).  
Systolic myocardial tissue velocity (S’): 
The systolic myocardial velocity S’ is above the baseline in TDI as mitral 
annulus moves towards apex during systole. 
Normal S’ velocity varies with age, sex and myocardial segments, and 
normal velocity of different segments as follows 32 
S wave cm/sec  
Myocardial segment 
Septal wall Lateral wall Inferior wall Anterior wall 
 Basal segment 5.97 + 1.14 6.26 + 2.44 6.52 + 1.31 6.44 + 2.32 
 Mid segment 6.29 + 1.89 4.48 + 0.92 5.21 + 2.79 5.1 + 1.16 
 Apical segment 4.42 + 2.3 4.81 + 1.97 2.97 + 1.14 3.8 + 2.66 
 
Early diastolic myocardial velocity (E’): 
    The early myocardial diastolic relaxation velocity 
measure below the baseline in TDI as mitral annulus moves away from 
apex. Its normal value is 12+4 cm/sec at rest and 15+5 cm/sec peak 
exercise. It varies with age, sex and segments as follows 32 
E’ wave cm/ sec 
Myocardial segment 
Septal wall Lateral wall Inferior wall 
Anterior 
wall 
 Basal segment 7.91 + 2.16 8.54 + 2.77 9.01 + 2.44 8.09 + 2.48 
 Mid segment 8.39 + 2.5 6.85 + 1.86 6.82 + 3.16 7.22 + 2.04 
 Apical segment 6.03 + 2.95 6.74 + 2.58 4.76 + 1.94 4.52 + 2.95 
     In normal heart without any impairment of 
relaxation E’ increases with increase in transmural gradient, increase in 
preload, dobutamine infusion and exercise. 
    Regional myocardial dysfunction and surgery 
involving mitral annulus can affect mitral annulus velocity. Lateral annulus 
velocity is lower than medial annulus velocity in lateral wall myocardial 
infarction. 
Late diastolic myocardial velocity (A’): 
It varies with above mentioned factors and its normal value as follows 32 
A’ wave cm/sec 
Myocardial segment 
Septal wall Lateral wall Inferior wall Anterior wall 
 Basal segment 5.99 +  1.73 3.77 + 1.95 5.84 + 2.06 3.86 + 1.75 
 Mid segment 4.87 + 2.14 4.9 + 1.72 2.62 + 1.84 4.78 + 1.7 
 Apical segment 2.69 + 1.93 3.77 + 2.1 3.08 + 1.54 1.69 + 1.45 
 
    Mitral annulus late diastolic velocity ( A’) is 
increase during early stage of diastolic dysfunction but decreases when 
atrial function deteriorates. 
Uses of TDI: 
1. Estimation  of LV filling pressure 
2. Early diagnosis of genetic disease like HCM, fabry disease 33 
3. To diffentiate HCM from athlete heart 34 
4. Assessment of RV function 35 
5. Differentiation between constriction and restrictive disease 36 
Definition of diastolic dysfunction: 
    Diastolic dysfunction is defined as abnormalities 
of ventricular filling during diastole. Abnormalities in diastolic function 
can occur in the presence or absence of a clinical syndrome of heart failure 
and with normal or abnormal systolic function 37. This is a disorder of left 
ventricular filling, which leads to reduction of LV end diastolic volume and 
cardiac output, during rest and exercise. Inability of left ventricle to fill 
without increase LV end diastolic pressure and mean LA pressure.  
Various pattern and grades of diastolic dysfunction described as follows, 
Grade 1 diastolic dysfunction: 
    This is a mild form of left ventricular diastolic 
dysfunction and is an early abnormality of diastolic function. The other 
names are given to grade 1 LVDD like delayed relaxation pattern, impaired 
relaxation pattern, reversed E/A ratio. In subjects with Grade 1 LVDD 
filling pressures are normal. They have E/A ratio < 1. Deceleration time is 
greater than 240 milliseconds.  
   Common cardiac conditions lead to this type of   
LVDD is LVH, myocardial ischemia, myocardial infarction, hypertrophic 
cardiomyopathy and diabetes mellitus. These patients can have increase in 
the IVRT. Various ECHO abnormalities noted in patients with DD are 
septal E’ less than 7 cm, mitral flow propagation velocity less than 50 
cm/sec and E/E’ greater than 8. 
Subgroups of patients with Grade I LVDD have a unique echo 
abnormality. They have E/A ratio less than 1 but E/E’ greater than 15 
indicating increase in filling pressure which is not usually seen in patients 
with grade 1 LVDD. This abnormality is designated as grade 1a LVDD.  
Grade 2 LV diastolic dysfunction: 
This grade refers to moderate form of LVDD. This form of diastolic 
dysfunction is also called pseudo normalization of LVDD. This 
echocardiographic pattern resembles the normal diastolic filling pattern 
such as E/A ratio between 1 to 1.5 and DT ranging 160 to 200 
milliseconds. The following points easily differentiate the pseudo 
normalization of diastolic dysfunction from normal diastolic filling pattern. 
1. Presence of  mid diastolic flow 
2. While valsalva manoeuvre the underlying impaired relaxation 
 pattern is unmasked, whereby E/A ratio decreases to > 0.5.  
3. During valsalva manoeuvre if A velocity increases – it indicates 
 pseudo normalization of diastolic dysfunction. 
4. Prolongation of pulmonary vein atrial flow reversal and shortening 
of mitral A duration which exceeds mitral A duration indicates the 
pseudo normalization of LVDD. 
5. E’ less than 7 
Grade 3 and 4 diastolic dysfunction: 
 These are the severe forms of LV diastolic dysfunction. The 
grade 3 LV diastolic dysfunction is a reversible form of diastolic 
dysfunction. The Grade 4 LV diastolic dysfunction is a irreversible form of 
diastolic dysfunction. These are also called as restrictive filling pattern or 
restrictive physiology. There are various cardiac abnormalities which can 
cause this severe type of restrictive diastolic dysfunction pattern are 
constrictive pericarditis, severe coronary artery disease, decompensated  
systolic heart failure, advanced restrictive cardiomyopathy  and acute 
severe aortic regurgitation. 
 The echocardiographic abnormalities that are noted in grade 3 and 4 
LVDD or severe diastolic dysfunctions are: 
1. Increased early transmitral velocity ‘E’ velocity 
2. Decreased late velocity ‘A’ (markedly reduced than ‘E’) 
3. E/A ratio greater than 2  
4. Decreased DT (less than 160 milli seconds) 
5. IVRT (less than 70 milli seconds) 
6. Pulmonary vein systolic forward flow velocity reduced  
7. Early mitral annulus velocity (E’ < 7cm/sec) is decreased  
8. E/E’ ratio is greater than 15. 
9. Valsalva manoeuvre reverses grade 3 diastolic dysfunction 
(reversible form of severe diastolic dysfunction) to grade 1 to 2 
pattern. But the grade 4 diastolic dysfunction cannot be reversed by 
Valsalva manoeuvre because LV filling pressure markedly elevated.  
 
Clinical applications of diastolic function assessment 
1. Echocardiographic assessment of diastolic function in patients with 
dyspnoea due to diastolic heart failure (DHF) or Heart failure with normal 
EF (HFnEF). 
2. Echocardigraphic assessment of diastolic dysfunction to differentiate 
dyspnoea from cardiac or non cardiac aetiology.  
3. To diagnose early changes of myocardial ischemia in the form of 
diastolic dysfunction in patients with early stages of ACS. 
4. To evaluate LV filling pressure due to various aetiology. 
5. To evaluate cardiac function in cardiomyopathy, 
6.  For prognostic assessment. 
OPD evaluation of Chest pain:  
    Acute chest pain is one of the leading symptom 
drives patient to hospital, clinics and physician office. The diagnosis of 
acute coronary syndrome (ACS) is made if the patient has typical angina 
pain, risk factors, ECG changes and positive cardiac enzymes. Only 15-
25% of patients present with acute chest pain diagnosed to have ACS38, 
remaining percentage of patients either non cardiac life threatening 
condition or a non cardiac non life threatening conditions or ACS without 
evidence of ACS. Patients presented with chest pain to hospital were 
discharged without ACS can actually have ACS in 2%. There are recent 
advances in early and accurate detection of ACS  by biomarkers , stress 
testing, radionuclide scanning and CT angiogram. Still ACS missed in 
patients with chest pain due to limitation of various testing modalities. To 
overcome these limitations various diagnostic modalities developed to 
detect myocardial ischemia in various stages of ischemic cascade. 
Ischemic cascade: 
We should know what happens to myocardium during ischemia and how it 
produces clinical manifestations. During the initial stages of coronary 
occlusion there is demand supply mismatch following that there is changes 
in biochemical milieu. Subsequently diastolic dysfunction develops as time 
progress wall motion abnormalities prone to occur. After the development 
of systolic dysfunction electrocardiographic changes manifest as a marker. 
Chest pain is the last manifestation to appear in myocardial ischemic 
cascade 39. 
    After restoration of blood flow to the ischemic 
segments clinical manifestation first to disappear and other systolic and 
diastolic abnormalities disappear subsequently within hours to days 
according to severity and duration of coronary occlusion. Alam et al 40 
studied 12 subjects undergoing PTCA  for chages during coronary 
occlusion by balloon angioplasty. Which showed reduced endocardial 
velocities,  thinning and systolic dysfunction. These changes occur 15-20 
secs after balloon occlusion and normalised within 15-20 secs after 
deflation of balloon. Myocardial ischemia causes diastolic dysfuntion by 
which it significantly increases LV end diastolic pressure and depression of 
EF without concurrent chestpain 41 
 
Non invasive methods of CAD detection: 
Exercise physiology:  
    Exercise testing is one of the important non 
invasive test modality evaluate cardiopulmonary status for stress. Exercise 
gives most physiologic way of stress and it increases cardiac output by six 
times and metabolic rate up to 20 times. Other modalities of non invasive 
testing can be combined with exercise test, so stress echocardiography, 
stress MPI and other stress modalities possible. These stress testing 
modalities gives functional, diagnostic and prognostic information. With 
exercise, in normal supine persons, the elevation of cardiac output results 
almost entirely from an increase in heart rate, with little augmentation of 
stroke volume. In the upright posture, the increase in cardiac output in 
normal individuals results from a combination of elevations in stroke 
volume and heart rate. 
Exercise capacity measured in standardised measurement of metabolic 
equivalents (METS), calculation of METS by following formula by 
treadmill exercise and bicycle ergometry. 
Vo2 ml/min/kg = (2.68x mph) x (0.1 + (gradex1.8))+3.5 
This oxygen consumption (Vo2) can be divided by 3.5 to metabolic 
equivalents. Cycle ergometry can be converted into treadmill METS by the 
following formula Oxygen extraction in the coronary circulation is almost 
maximal at rest. The only significant mechanism available to the heart to 
increase oxygen consumption is to increase perfusion, and there is a direct 
linear relationship between Mo2 and coronary blood flow in normal 
individuals. The principal mechanism for increasing coronary blood flow 
during exercise is to decrease resistance at the coronary arteriolar level. In 
patients with progressive atherosclerotic narrowing of the epicardial 
vessels, an ischemic threshold occurs, and exercise beyond this threshold 
can produce abnormalities in diastolic and systolic ventricular function, 
electrocardiographic changes, and chest pain. 
Treadmill METS = 0.98(Cycle ergometry METS) + 1.85 
Stress ECG: 
     It is one of the several, frequently done non 
invasive techniques to diagnose myocardial ischemia in patients with 
known or suspected coronary artery disease. It measures various 
parameters during test. Other than ST segment changes, it also gives 
information about blood pressure, heart rate, exercise capacity, heart rate 
recovery, chest discomfort and others.   Stress ECG always low cost and 
safe procedure but others like stress echo and stress SPECT are costly and 
need for pharmacologic agents and radioactive material.  However all these 
non invasive methods have inherent limitations. Stress ECG has sensitivity 
of 27-75% in patients with single vessel disease but it increases as number 
of vessel increased. Patients with multivessel disease have sensitivity of 
81% and specificity of 66%. For left main disease and triple vessel disease 
the sensitivity and specificity is around 86% and 53% respectively. So the 
overall sensitivity and specificity of the exercise ECG in patients with CAD 
is approximately 68% and 77% respectively. The prevalence of an 
abnormal stress ECG in middle-aged asymptomatic men and women ranges 
from 5-12% and 20% - 30% respectively 42 
There are various exercise test modalities available, as follows 
1. Arm ergometry 
2. Bicycle ergometry 
3. Treadmill exercise 
Exercise protocols: 
There are various types of protocols available, decided according to patient 
clinical status 
1. Bruce and modified bruce proctocol- most commonly used  
the most commonly used protocol which uses three minutes 
stages with grades and it steadily increases oxygen consumption. 
Modified protocol used in elderly population as warm up for 
bruce stages. 
2. Balke-ware protocol 
3. Cornell protocol 
4. ACIP and mACIP protocol 
Uses two minute stages after first two one minute stages but it 
gives gradual increase in heart rate, used in established CAD 
5. Weber protocol 
It uses two minutes stages with 1 METS increament and it used in 
limited exercise capacity like compensated congestive heart 
failure  
6. Naughten protocol 
It also uses two minutes stages with 1 METS increment. 
7. Ellested protocol 
8. Mc henry protocol 
Pre test probability of CAD by exercise testing can be decided according to 
age, sex and symptoms, these are follows 
1. Very low pre test probability < 5% 
2. Low pre test probability 5- 10% 
3. Intermediate pre test probability 10-90% 
4. High pre test probability > 90% 
 
Stress echocardiography: 
    Stress echocardiography is done using exercise or 
pharmacologic agents to provoke ischemia. Echocardiographic images 
examined and stored while the patient is at rest and during (or) immediately 
after stress (1 to 2 minutes after exercise) are compared in same plane. The 
test is positive if it shows wall-motion abnormalities with stress in 
previously normal myocardial segments or worsens in a myocardial 
segment that was abnormal before stress. It is true that radionuclide 
perfusion imaging, stress echocardiography gives information about area 
and extent of ischemic myocardium. 
Types of stress echocardiography 
There are various forms of stress echocardiography of which few 
commonly used as follows 
I. With exercise 
  1. Isometric exercise 
  2. Arm ergometry 
  3. Supine bicycle exercise 
  4. Immediate post treadmill exercise 
 
II. Without exercise 
  1. Pharmacologic stress  
   a. Dobutamine 
   b. Dypiridamole 
   c. Adenosine, rarely ergonavine 
      III.     Other stress 
  1. Atrial pacing 
  2. Oesophageal atrial pacing 
  3. Hyperventilation 
  4. Cold pressor 
Immediate post treadmill echocardiography: 43 
    It is not possible to do echocardiography in a 
subject walking upright, so exercise echo designed to do before and 
immediately after cessation of exercise. During treadmill exercise echo 
typically four views captured in digital format and analysed subsequently. 
The views are PLAX, PSAX, A4C, and A2C. Any of standard exercise 
protocol can be combined with echo. During treadmill electrodes placed in 
such a way that echo window available to complete the task. After getting 
baseline echo images and treadmill test in standard protocol is completed 
with traditional endpoints. There no cool down period allowed in this 
protocol. Post tread mill echocardiogrphic images acquired with one to two 
minutes after completion of treadmill. 
Supine bicycle exercise echocardiography: 44 
A 2 D echocardiography is done during rest and LV parameters measured 
at subject with left lateral position. Supine bicycle exercise performed by 
the subject to undergo stress which is multistage exercise with variable 
load. Patients pedalled at same speed with different work load that is 25W 
increment at every three minutes. During each stage and recovery of supine 
bicycle exercise 2D echo done and various parameters measured at various 
planes.  
Pharmacologic stress echocardiography: 
Pharmacologic and Exercise stress echocardiography is a mostly accurate 
physiological non-invasive technique for evaluating coronary artery 
disease, with high sensitivities and speciﬁcities (80 vs. 85%) 45, 46, 47. The 
sensitivity for stress ECHO varies with number of coronary artery 
involvement and its 58% for SVD and 86% for double vessel disease 
finally 96% for three vessel disease. It unmasks perfusion defects in the 
form of wall motion abnormality. It is possible with experts, not easy for 
beginners and others moreover its subjective assessment, it can vary with 
experts. The use of pharmacological agents like dobutamine, adenosine and 
dypyridamole is essential. During last decade the tissue Doppler imaging 
proposed as valuable alternative technique for detection of myocardial 
ischemia as an objective tool. 
Contraindication for stress echocardiography: 
 Stress echocardiography should not be done within 24 hours of 
troponin positive ACS and within seven days after STEMI. 
 Life threatening arrhythmia in the recent past 
 pulmonary embolism and  infarction 
 LVF with symptoms 
 Severe fixed LVOT obstruction. 
 BP greater than 220/120 
 Severe form of  hyperkalemia 
 Acute form of myocrditis,endocarditis, pericarditis, 
 Acute DVT, thrombophlebitis. 
 Any form of  bronchospasm, blood pressure less than 90mmHg, 
 Second or third degree AV block and sick sinus syndrome without 
pacemaker in dobutamine stress test. 
 
 
Stress SPECT: 
    SPECT imaging uses radioactive materials to 
detect myocardial ischemic territories and it has its own limitations. Its 
sensitivity for SVD, DVD and TVD is around 61%, 86% and 94% 
respectively. Exercise SPECT has Sensitivity to detect CAD 87% (range, 
71% to 97%) and specificity 73% to rule out CAD. Pharmacologic stress 
agents combined with SPECT MPI showed sensitivity of 89% and 
specificity of 75%, it was similar to exercise SPECT. 
 
CT coronary angiogram: 
Cardiac CT angiography is one of method for early detection of CAD in 
asymptomatic individuals with low and intermediate risk for CHD. It has 
sensitivity of 93% and specificity of 85%. Cardiac CT angiogram one of 
the investigation has high negative predictive value of around 99% 48  CT  
coronary angiogram has high negative predictive value for CAD.  
Coronary angiography is gold standard method to detect and quantify CAD 
in any individuals 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
METHODS AND 
MATERIALS 
     
    METHODS AND MATERIALS 
Patient: This analytical pre and post cross sectional study was 
conducted from September 2013 to February 2014. The study population 
includes patients attended the cardiology department OPD Stanley medical 
college hospital with complaints of chest pain and they are investigated 
subsequently they were submitted for stress ECG. 
Inclusion criteria  
Patients aged from 25 to 75 years who are presented to OPD with chest 
pain with normal LV function without ACS. 
Exclusion criteria  
Who not able to walk 
Atrial fibrillation, 
Patients with recent MI/NSTEMI/USA 
More than stage 1 hypertension 
Chronic kidney disease. 
Valvular heart disease 
ECG presence of Q wave, with bundle branch pattern/IVCD 
     EF of < 45% 
Procedure: 
• Blood test done at OPD/on admission before CAG  
• Treadmill test is performed with HUSTRO- CARIOTRACK 
machine using bruce and modified bruce protocol. 
• Stress echocardiography is performed using a standard ultrasound 
system (PHILIPS HD 11 XE Philips electronics, Netherlands)  with a 
2-4-MHz transducer during rest, at 1st min of recovery 
Patients studied in left lateral position using Philips 11XE using 2-4 
MHz baseline parameters obtained before TMT. After completion of 
prespecified end points, patient immediately shifted to echo table 
which available by the side of TMT. Wall motion analysis and mitral 
inflow parameter and TDI parameters measured. Apical 4 chamber 
and apical 2 chamber view used to measure TDI parameters in basal 
septal, basal lateral and basal inferior wall.  
 
 
 
 
 
Fig.1 Baseline E, A measurement in mitral Doppler echo 
 
Fig.2 Post TMT stress mitral Doppler echo- reversal E/A ratio 
 
Fig.3 Baseline TDI measurements: basal anterior septum 
 
Fig. 4 Post TMT stress TDI measurements: basal anterior septum 
 
Fig.5 Baseline TDI measurement: basal lateral wall 
 
Fig.6 Post TMT stress TDI measurement: basal lateral wall 
 
 • Coronary angiography is performed with Siemens axiom altis and 
images recorded at a frame rate of 15/s. The patients with coronary 
artery lesion were identified and its severity assessed by gensini 
score and syntax score by experienced cardiologist 
 
The Gensini score 49 is one method used to calculate severity in 
angiographic lesions and checked by a team of cardiologist. The 
score assigns increasing numbers to more severe luminal narrowing 
and also gives weight to individual segments of coronary artery 
affected according to vessel size and significance; segments that 
supply larger regions are more heavily numbered. 
 
 
 
 
 
 
 
 
 
Syntax score50; 
It is an angiographic tool to grade complexity of CAD and 
ddetermines which patient amenable to which strategy, and it is semi 
quantitative visual score. This gives an idea about anatomical 
complexity anticipates procedural difficulty and outcome 
 Algorithm contains 12 questions 
  Q 1- DOMINANCE 
  Q2- TOTAL NO OF VESSEL  
  Q3 –LEISON LOCATION 
  Q 4-12 LEISON CHARACTERISTICS  
When the total scores calculated, it predicts MACCE and 
TREATMENT STRATEGY according to the score. 
 < 22 PCI preferable, 
 >22 to 32 < CABG better than PCI, 
 > 32 CABG definitely better and PCI with adverse events.  
 
 
 
  
 
Figure - 7 Coronary angiogram of  LCA 
 
 
 
 
 
Statistical analysis:  
    The descriptive statistics was done for all data 
collected and suitable statistical test used for comparison. Continuous 
variables were analysed using unpaired t-test and Anova, categorical 
variables were examined with the Chi-Square Test with Yates correction. 
Statistical significance was taken for all correlation as p- value < 0.05. Our 
all data was analysed by using EpiInfo software 7.1.0.6 version; C D C, 
USA and Microsoft Excel 2010. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RESULTS 
 
 
RESULTS: Table – 1 Age distribution in our study 
Age CAD+ % CAD- % 
21 to 30 2 4.88 0 0 
31 to 40 2 4.88 1 10 
41 to 50 11 26.83 6 60 
51 to 60 11 26.83 2 20 
61 to 70 15 36.59 1 10 
Total 41 100 10 100 
 
Table – 2 Average age distribution 
 Age CAD+ CAD- 
N 41 10 
Mean 53.88 49.9 
SD 10.22 7.85 
P value 0.9729 
 
Table – 3 Average age in gender  
Gender CAD+ % CAD- % 
Male 27 65.85 4 40 
Female 14 34.15 6 60 
Total 41 100 10 100 
P value 0.1627 
 
  Age distribution 
 
Gender Distribution  
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 Table – 4 Smoking status comparison to CAD 
Smoking Status CAD+ % CAD- % 
SMOKING+ 18 43.90 3 30 
SMOKING- 23 56.10 7 70 
Total 41 100 10 100 
P value 0.4272 
 
Table – 5 Hypercholestrolemia distributions in CAD patients 
Hypercholesterolemia CAD+ % CAD- % 
Hypercholesterolemia 17 41.46 0 0 
Normal 24 58.54 10 100 
Total 41 100 10 100 
 
Table – 6 Average total cholesterol level in CAD 
Age CAD+ CAD- 
N 41 10 
Mean 230.29 204.50 
SD 41.26 22.96 
P value 0.01349* 
*P value is significant 
 
 Smoking status: 
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 Table – 7 Distribution hypertension in CAD patients 
Hypertension Status CAD+ % CAD- % 
Hypertensive  15 36.59 4 40 
Normal  26 63.41 6 60 
Total 41 100 10 100 
 
Table – 8 Diabetes distributions in our study:  
Diabetic Status CAD+ % CAD- % 
Diabetic  17 41.46 4 40 
Normal  24 58.54 6 60 
Total 41 100 10 100 
P value 0.9328 
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Table – 9 Correlation family history to CAD 
Family History of 
CAD CAD+ % CAD- % 
CAD+ 17 41.46 1 10 
CAD- 24 58.54 9 90 
Total 41 100 10 100 
P value 0.0771* 
*significant 
Table – 10 LDL distributions in CAD 
LDL (mg/dl) CAD+ % CAD- % 
<100 3 7.32 1 10 
100 to 129 10 24.39 6 60 
130 to 159 10 24.39 2 20 
160 to 199 15 36.59 1 10 
>200 3 7.32 0 0 
Total 41 100 10 100 
 
Table – 11 Average LDL level correlation to CAD  
LDL (mg/dl) CAD+ CAD- 
N 41 10 
Mean 152.76 128.50 
SD 35.97 22.49 
P value 0.01385* 
*significant 
 Family history of CAD: 
 
 
 LDL Status: 
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Table – 12 Non HDL level distributions in CAD 
Non HDL (mg/dl) CAD+ % CAD- % 
<100 0 0 0 0 
100 to 129 2 4.88 1 10 
130 to 159 10 24.39 6 60 
160 to 199 12 29.27 3 30 
>200 17 41.46 0 0 
Total 41 100 10 100 
 
Table – 13 Average level of Non HDL in CAD 
Non HDL (mg/dl) CAD+ CAD- 
N 41 10 
Mean 190.49 159.00 
SD 42.90 23.33 
P value 0.00398* 
*significant 
 
 
 
 
 
  
 
 
Non HDL level in the study: 
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Table – 14 Hemodynamic measurements at rest and peak stress:  
Haemodynamic 
Measurements 
CAD+ 
CAD- 
P  value 
N Mean SD N Mean SD 
Basal HR 41 70.85 10.59 10 72.50 11.89 0.6952 
Max HR 41 155.49 16.92 10 165.00 15.10 0.1017 
BP Rest Systolic 41 127.07 6.81 10 130.40 6.79 0.1868 
BP Rest 
Diastolic 
41 84.12 6.53 10 86.80 4.73 0.1560 
BP Peak Systolic 41 164.10 14.68 10 173.20 12.01 0.0566* 
BP Peak 
Diastolic 
41 102.49 8.90 10 106.20 11.41 0.3562 
 *peak systolic BP is significant 
 
 
 
 
Table – 15 Echocardiographic findings at rest: 
ECHO 
Findings 
CAD+ CAD- P  value 
N Mean SD N Mean SD 
E 41 76.46 17.66 10 87.60 23.36 0.18408 
A 41 85.15 20.83 10 103.30 12.84 0.002058* 
E/A 41 0.94 0.29 10 0.86 0.30 0.482381 
DT 41 215.78 33.21 10 215.80 33.21 0.416758 
S' septal 41 6.00 1.22 10 7.74 1.62 0.008127* 
E' septal 41 7.87 1.81 10 10.10 2.26 0.013177* 
A' septal 41 7.18 1.68 10 8.63 1.66 0.027266* 
E/E' septal 41 9.72 1.07 10 8.60 0.82 0.001941* 
E'/A' septal 41 1.10 0.18 10 1.18 0.17 0.231774 
S' lateral 41 6.84 1.42 10 9.03 1.78 0.00353* 
E' lateral 41 8.79 2.15 10 11.39 2.55 0.011101* 
A' lateral 41 7,62 2.29 10 9.06 2.15 0.081208 
E/E' lat 41 8.78 1.10 10 7.69 1.12 0.014659* 
E'/A' lat 41 1.22 0.36 10 1.29 0.36 0.552829 
S' inferior 41 5.93 1.17 10 7.59 1.63 0.01092* 
E' inf 41 7.97 1.85 10 9.93 2.52 0.039751* 
A' inf 41 7.29 1.70 10 8.56 1.59 0.041393* 
E/E' inf 41 9.63 1.27 10 8.85 1.19 0.087578 
E'/A' inf 41 1.10 0.19 10 1.15 0.16 0.4915 
avg S' 41 6.25 1.24 10 8.11 1.63 0.005654* 
avg E' 41 8.20 1.87 10 10.47 2.41 0.017041* 
avg A' 41 7.37 1.81 10 8.75 1.62 0.032222* 
avg E/E' 41 9.37 0.99 10 8.37 0.98 0.011798* 
*significant statistically 
Table – 16 Echocardiographic findings immediately after TMT: 
ECHO 
Findings 
CAD+ CAD- P  value 
N Mean SD N Mean SD 
E 41 103.37 22.49 10 111.70 21.28 0.29036 
A 41 103.38 21.34 10 98.80 12.26 0.33507 
E/A 41 1.01 0.24 10 1.12 0,16 0.09712 
DT 41 193.61 442.80 10 181.10 18.50 0.16791 
S' septal 41 6.84 1.42 10 9.57 2.07 0.00221* 
E' septal 41 8.14 2.16 10 11.98 2.78 0.00159* 
A' septal 41 7.83 1.99 10 9.85 2.18 0.01958* 
E/E' septal 41 13.15 2.23 10 9.46 1.19 <0.0001* 
E'/A' septal 41 1.04 0.15 10 1.21 0.13 0.00227* 
S' lateral 41 7.51 1.83 10 10.51 2.21 0.00181* 
E' lateral 41 9.02 2.52 10 13.13 3.01 0.00169* 
A' lateral 41 8.29 2.37 10 10.01 1.96 0.03013* 
E/E' lat 41 11.99 2.12 10 8.64 1.19 <0.0001* 
E'/A' lat 41 1.09 0.18 10 1.31 0.17 0.00363* 
S' inferior 41 6.84 1.47 10 9.13 1.59 0.00116* 
E' inf 41 8.56 2.24 10 22.60 35.36 0.24119 
A' inf 41 7.90 1.87 10 9.73 2.04 0.02249* 
E/E' inf 41 12.44 2.18 10 9.81 1.37 0.0001* 
E'/A' inf 41 1.08 0.16 10 1.16 0.12 0.10892 
avg S' 41 7.06 1.49 10 9.74 1.92 0.00147* 
avg E' 41 8.58 2.17 10 12.19 2.17 0.00204* 
avg A' 41 8.00 2.02 10 9.85 1.95 0.01824* 
avg E/E' 41 12.52 1.85 10 9.29 1.21 <0.00001* 
*significant statistically 
Table – 17 Echo findings difference:  
ECHO 
Findings 
CAD+ CAD- 
P  value 
N Mean SD N Mean SD 
E 41 26.90 18.18 10 24.10 7.29 0.44839 
A 41 18.68 29.26 10 -4.50 21.74 0.01166* 
E/A 41 0.08 0.38 10 0.26 0.25 0.07872 
DT 41 -12.17 64.20 10 -34.70 37.55 0.16017 
S' septal 41 0.84 0.62 10 1.83 0.80 0.00330* 
E' septal 41 0.27 1.24 10 1.88 0.75 <0.0001* 
A' septal 41 0.65 1.18 10 1.22 0.82 0.08983 
E/E' septal 41 3.43 2.31 10 0.86 1.25 0.0001* 
E'/A' septal 41 -0.06 0.23 10 0.03 0.09 0.04658* 
S' lateral 41 0.68 0.75 10 1.48 0.55 0.00115* 
E' lateral 41 0.23 1.18 10 1.74 0.70 <0.0001* 
A' lateral 41 0.67 1.04 10 0.95 1.17 0.49984 
E/E' lat 41 3.21 2.04 10 0.95 1.12 0.0001* 
E'/A' lat 41 -0.12 0.29 10 0.01 0.23 0.13412 
S' inferior 41 0.91 0.59 10 1.54 0.44 0.00143* 
E' inf 41 0.60 0.97 10 12.67 35.05 0.30439 
A' inf 41 0.60 0.79 10 1.17 0.69 0.03899* 
E/E' inf 41 2.81 2.03 10 0.96 1.34 0.00223* 
E'/A' inf 41 -0.02 0.15 10 0.02 0.11 0.39922 
avg S' 41 0.81 0.51 10 1.63 0.46 0.00017* 
avg E' 41 0.38 0.94 10 1.73 0.62 <0.0001* 
avg A' 41 0.63 0.84 10 1.10 0.71 0.09305 
avg E/A' 41 3.15 1.92 10 0.93 1.21 0.00015* 
*significant statistically 
Table – 18 Distribution of various categories to TMT positivity and 
negativity 
TMT with Pretest 
Probability of CAD TMT+ % TMT- % 
Low 1 2.63 4 30.77 
Intermediate 32 84.21 9 69.23 
High 5 13.16 0 0.00 
Total  38 100 13 100 
P value 0.007* 
*significant 
Table – 19 Distribution of TMT duration and CAD 
TMT Exercise 
Duration CAD+ % CAD- % 
≤2.5 0 0 0 0 
2.6 to 5 15 36.59 0 0 
5.1 to 7.5 15 36.59 1 10 
7.5 to 10 11 26.83 9 90 
Total 41 100 10 100 
 
Table – 20 Correlation of TMT duration with CAD 
TMT Exercise Duration CAD+ CAD- 
N 41 10 
Mean 6.21 8.68 
SD 1.95 0.92 
P value <0.0001* 
*significant 
 TMT comparing pre test probability of CAD 
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Table – 21 E/E’ correlation with SVD  
 SVD+ SVD- P  value 
N Mean SD N Mean SD 
Avg E/e' 
Baseline 38 9.29 1.00 13 8.83 1.18 0.21839 
Avg E/e' After 
Exercise 38 12.18 1.89 13 11.03 2.71 0.178659 
Avg E/e' 
Difference 38 2.88 2.01 13 2.21 1.97 0.300169 
 
Table – 22 DVD correlation with E/E’ 
 DVD+ DVD- P  value 
N Mean SD N Mean SD 
Avg E/e' 
Baseline 38 9.27 1.03 13 8.88 1.12 0.2808 
Avg E/e' After 
Exercise 38 12.29 2.09 13 10.70 2.00 0.0226* 
Avg E/e' 
Difference 38 3.02 2.07 13 1.82 1.54 0.0353* 
*more significant 
Table – 23 TVD correlation with E/E’ 
 TVD+ TVD- P  value 
N Mean SD N Mean SD 
Avg E/e' 
Baseline 38 9.40 1.01 13 8.51 0.94 0.0079* 
Avg E/e' After 
Exercise 38 12.65 1.84 13 9.65 1.32 <0.0001* 
Avg E/e' 
Difference 38 3.25 1.95 13 1.14 1.19 0.0001* 
*more significant 
  
Table – 24 Multivariate regression analyses: 
Variable  Odds ratio 95% CI P value 
Smoking  1.8261 0.4130 to 8.0745 0.4272 
Hypercholesterolemia 15.000 0.8232 to 273.3360 0.0675 
Hypertension  0.8645 0.2101 to 3.5652 0.8414 
Diabetes  1.0625 0.2595 to 4.3498 0.9328 
Positive Treat Mill 
Exercise Test 
1.3286 0.2880 to 6.1286 0.07157 
Presence of WMA after 
exercise 
71.8421 3.8448 to 1342.3922 0.0042* 
Increase of E/E’ average 
after exercise 
3.1667 0.0250 to 10.9591 0.2454 
*significant 
 
 
 
 
 
 Table – 25 Correlation of E/E’ to severity of CAD by Gensini score 
Gensini 
Score 
0 1 to 10 11 to 40 >40 P value 
N Mean SD N 
Mea
n SD N 
Mea
n SD N 
Mea
n SD  
Avg E/e' 
Baseline 
1
0 8.37 
0.9
8 
1
9 9.01  
0.9
1 
1
7 9.23 
1.0
6 5 9.64 
1.0
0 
0.020649
* 
Avg E/e' 
After 
Exercise 
1
0 9.29 
1.2
1 
1
9 
11.2
6 
1.6
8 
1
7 
13.5
9 
1.3
1 5 
13.6
3 
0.7
4 <0.0001* 
Avg E/e' 
Differenc
e 
1
0 0.93 
1.2
1 
1
9 2.03 
1.7
0 
1
7 3.96 
1.6
8 5 4.62 
1.1
4 <0.0001* 
*significant 
 
Table – 26 Correlation of E/E’ to severity of CAD by Syntax score 
Syntax 
Score 
0 1 to 22 23 to 32 >32 
P value 
N Mean SD N 
Mea
n SD N 
Mea
n SD N 
Mea
n SD 
Avg E/E' 
Baseline 
1
0 8.37 
0.9
8 
3
4 9.33 
0.8
7 3 
10.1
6 
2.1
9 4 9.09 
0.8
7 
0.021013
* 
Avg E/E' 
After 
Exercise 
1
0 9.29 
1.2
1 
3
4 
12.1
7 
1.8
0 3 
14.3
2 
1.0
2 4 
14.1
3 
1.0
2 <0.0001* 
Avg E/E' 
Differenc
e 
1
0 0.93 
1.2
1 
3
4 2.83 
1.9
0 3 4.17 
1.9
1 4 5.04 
0.6
3 
0.000709
* 
     
 Distribution of E/E’ with Gensini score 
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DISCUSSION 
 
 
    DISCUSSION 
    In my study we had 51 patients completed all the 
requirements for analysis out of 72 patients. Seven patients did not undergo 
various procedures which required for our study and 10 patients echo 
recordings were suboptimal and two patients with history of old myocardial 
infarction. In our study 53 years of age is average for coronary artery 
disease whereas those without CAD were < 50 years. Majority of patients 
was in our study between 40 to 70 years of age.  
    Male gender is one of non modifiable risk factor 
which reflected in our study that 65% diagnosed with CAD whereas female 
only 34%. Smoking status doesn’t carry any statistical significance in our 
study but 43% were smokers in CAD group. Dyslipidemia is one of the 
strong predictor of CAD in our study and its average TC associated with 
CAD was 230 mg% p value 0.013.   LDL and NON HDL levels had strong 
correlation in our study with statistical significance. The CAD positive 
patients had average LDL of 153 mg/dl than 128 mg/dl for without CAD. 
The NON HDL level of 190 mg/dl had good correlation to CAD than 159 
mg/dl for without CAD.  Hypertensive patients in our study are low 
because we included only grade I hypertension in our study. It doesn’t 
show any correlation to CAD. The baseline systolic BP in both groups were 
almost equal (130 mmhg) both groups. We had 21 patients with diabetes; 
majority 17 out of 21 had CAD. Patients with h/o CAD in family had 
higher chances of CAD which correlated significantly. Patients with 
coronary artery disease had lower peak systolic BP during TMT than others 
(164 vs 173), which has p value of 0.0566.   And the peak HR also 10 
beats/min is less in CAD group than non CAD group but did not correlate 
significantly. Baseline TDI systolic velocity (S’) was lower in CAD 
patients than without CAD (6.25 vs 8.11 cm/sec) which shown in other 
studies. Our study had lower E’ and A’ in patients with coronary artery 
disease. But E/E’ slightly higher than normal value in CAD group (9.37 vs 
8.37). Tissue Doppler systolic velocity for different segments in baseline 
mainly basal septal, basal lateral and basal inferior are 8.11, 10.47 and 8.75 
cm/sec respectively. There were significant changes tissue Doppler echo 
parameters in patients with CAD after stress test. The systolic velocity did 
not increase after stress test in patients with coronary artery disease.  
    Baseline Tissue Doppler average early and late 
diastolic velocity in our study is 10.47 cm/sec and 8.37 cm/sec. The 
diastolic parameters E prime and A prime was not competitively increased 
in CAD group.  But there was decrease in E velocity and increase in A 
velocity as occur in other studies. Average E/E’ ratio of all three 
myocardial segments measured is significantly increased and the increasing 
change (3.15) well correlated with CAD detection in diastolic stress test.  
     The average increase in E/E’ ratio well correlated 
in patients with positive TMT. Duration of exercise time is low in patients 
with CAD than without CAD (6.21 vs 8.68 min). Patients with negative 
TMT and normal CAG higher exercise capacity, peak systolic pressure, 
low LDL, low NON HDL, normal S’ velocity and same E/E’ ratio before 
and  after stress. The increase in E/E’ ratio did not correlate with SVD but 
well correlated with double vessel disease and triple vessel disease. The p 
value of our study was significant in univariate analysis but was not 
significant in multivariate analysis   
    When patients were divided into four subgroups 
according to Gensini scores and compared with Average E/E' Baseline/ 
Average E/E' After Exercise/ change in Average E/E', all these parameters 
incrementally increased as Gensini score increased. There is a statistically 
significant correlation between E/e’ groups and Gensini scores (Average 
E/E' Baseline – p=0.020649, Average E/E' After Exercise – p=0.0000 and 
Average E/E' Difference – p=0.0000).In simple terms we can conclude that 
E/E’ is an independent predictor of severity and extension of coronary 
stenosis as indicated by Gensini scores. The same time Syntax scores 
compared with Average E/E' Baseline/ Average E/E' After Exercise/ 
change in Average E/E', all these parameters incrementally increased as 
Syntax score increased.  There is a statistically significant correlation 
between E/E’ groups and Syntax scores (Average E/e' Baseline – 
p=0.021013, Average E/E' After Exercise – p=0.0000 and Average E/E' 
Difference – p=0.000709). In simple terms we can conclude that E/E’ is an 
independent predictor of complexity of coronary artery disease as indicated 
by Syntax scores 
    In our study TMT positive had 56% sensitivity 
for detection of CAD, but it is around 68% in tsougos study, when 
combining increase in E/E’ value with stress echocardiography its 
sensitivity rose to 71%. Moreover including objective measurement of wall 
motion abnormalities with other parameters sensitivity for detection of 
CAD as high as 75% in our study, but tsougos et demonstrated that 
combining all the above parameters sensitivity was 97%. Our study did not 
reach 97% sensitivity due to various factors which is mentioned in study 
limitations. Still it increases sensitivity to detect coronary artery disease. It 
needs further study with larger population to decide E/E’ as sensitive 
marker to diagnose CAD. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
STUDY LIMITATIONS 
 
     LIMITATIONS OF STUDY 
1. TDI measurements are time consuming and there may be change in 
parameters if recorded later than 1-2 mins after completion of TMT 
2. There is overlapping of waveforms during tachycardia and difficulty in 
measurements 
3. During velocity calculation the motion of measuring segments may be 
altered by adjacent scarred or normal segments. 
4. Our study was looking at patients mainly with intermediate pre test 
probability of CAD, where patients are younger than others studies. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CONCLUSION 
     
    CONCLUSION 
1. The systolic velocity S’ is reduced in  patients with obstructive CAD 
2. The average E/E’ ratio in Indian population during rest without CAD 
is 8.37 but slightly increased in CAD patients ( 9.37 ) 
3. There is significant reduction of all diastolic parameters E’, A’ with 
stress test noted in patients with CAD 
4. A significant increase in E/E’ ratio (3.15 + 1.92) from baseline 
irrespective of baseline value during stress test highly correlated with 
presence of obstructive CAD. 
5. The baseline and stress E/E’ ratio incrementally increased as severity 
of CAD increases. 
6. Post treadmill exercise echocardiography using TDI to measure E/E’     
 ratio increases sensitivity of CAD detection form 56% to 71% in our 
 study. 
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Address: 
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History: 1. Chest pain -typical/atypical  2. Dyspnea –NYHA class-
 3.Others   
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Drug therapy 
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W/H ratio: 
CVS:                                    RS: 
CXR- PA view: 
ECG: 
TMT: Protocol- Bruce/modified Bruce 
Basal HR -  Max HR -   APMHR –  
BP at REST -  BP at PEAK exercise -  
Total duration of exercise-  METs- 
Reason to stop -  positive/inconclusive/negative 
ECHO:  
IVSd / IVSs:                                 LVIDd:                                    AO/LA diameter (M mode): 
 LV PWd/ PWs:                           LVIDs: 
EF (TEICHOLZ):       
RWMA: 
 Before exercise After exercise 
LAD territory   
LCX territory   
RCA territory   
 
Mitral valve:                                    Aortic valve:                                      Tricuspid valve:                       
PHT 
Diastolic dysfunction:  
 Before exercise After exercise 
E   
A   
E/A   
DT   
 
Tissue  Doppler velocity: 
TDI- velocity  
m/sec 
Before exercise After exercise 
 Septal Lateral Inferior Avg Septal Lateral Inferior avg 
S’         
E’         
A’         
E/E’         
E’/A’         
 
RA/RV function:                                     pericardial effusion:                                        
 
 
 
INVESTIGATIONS 
Hb:               RBS:                   UREA:              CREATININE:                ELECTROLYTES -   NA/K: 
CPK: CPK-MB:  Troponin-T: 
 
 
LIPID PROFILE: T.CHOLESTEROL: TGL:  LDL: HDL: 
Non HDL: 
 
CARDIAC CATHETERIZATION: 
Coronary angiogram: 
 
Gensini score: 
 
Syntax score: 
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ேநாயாளக¶tகான ஆேலாசைன 
jpwd; Cf;fpa bky;byhyp ,ja Ma;t[. khuilg;ig 
fz;Lgpof;Fk; g[jpa nrhjid Kiw/ jir bky;byhyp 
,ja Ma;t[  பறி நா} ஒ¯ ஆº ேமெகாz உேள}. 
இ|த கzகாணtக~பyட ம¯{¢வ ஆவ தாuக¶ பதிº ெச¢ 
தuகள¢ «¸ ஒ{¢ைழ~ைப நமா² தuகைள அ}©ட} 
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இதனா ஏபடய பtக வைளºக பறி ம¯{¢வƬ} ¬ல 
ெதƬ|¢ெகாzேட}.  
பƬேசாதைன  ம² நட{த~ப ஆைவ பறி «¸ைமயாக ம¯{¢வƫ 
வளtகினாƫ. நா} இ|த ஆவ பuெகtக «¸ மன¢ட} சமத 
ெதƬவகி}ேற} . 
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ேநாயாளய} ஒ~©த பவ 
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பu ெப²பவƫ இதைன (     )  றிtகº 
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